DOCSLIB.ORG

VITEK® MS V3 Organism List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
VITEK® MS V3 Organism List VITEK® MS V3 Organism List FDA CLAIMED ORGANISMS ANAEROBES Actinomyces meyeri Finegoldia magna Database Version 3 features 1,046 clinically significant Actinomyces neuii Fusobacterium necrophorum organisms including bacteria, yeast, Mycobacteria, Nocardia, Actinomyces odontolyticus Fusobacterium nucleatum and molds. Bacteroides caccae Mobiluncus curtisii Bacteroides fragilis Parvimonas micra • Deliver rapid, actionable results to clinicians to support Bacteroides ovatus/xylanisolvens Peptoniphilus asaccharolyticus informed treatment decisions. Bacteroides thetaiotaomicron Peptostreptococcus anaerobius Bacteroides uniformis Prevotella bivia • Simple, safe, and effective inactivation and extraction Bacteroides vulgatus Prevotella buccae protocols offer excellent performance for identification of Clostridium clostridioforme Prevotella denticola Mycobacteria, Nocardia, and molds Clostridium difficile Prevotella intermedia Clostridium perfringens Prevotella melaninogenica • Easy workflowwith convenient, prepackaged reagent kits Clostridium ramosum Propionibacterium acnes • In-lab solution to save time and costs compared to sending out tests or using other identification methods GRAM-POSITIVE Abiotrophia defectiva Staphylococcus cohnii ssp cohnii • More than 15,000 distinct strains account for diversity within a Aerococcus viridans Staphylococcus cohnii ssp urealyticus species for greater accuracy Corynebacterium jeikeium Staphylococcus epidermidis The only Mass Spectrometry instrument FDA 510(k) cleared for Enterococcus avium Staphylococcus haemolyticus Enterococcus casseliflavus Staphylococcus hominis Mycobacteria, Nocardia, and molds. Enterococcus cecorum Staphylococcus lugdunensis Enterococcus durans Staphylococcus saprophyticus Enterococcus faecalis Staphylococcus schleiferi Enterococcus faecium Staphylococcus sciuri Enterococcus gallinarum Staphylococcus simulans Gardnerella vaginalis Staphylococcus warneri Gemella haemolysans Streptococcus agalactiae Gemella morbillorum Streptococcus anginosus Granulicatella adiacens Streptococcus constellatus Streptococcus dysgalactiae ssp Lactococcus garvieae dysgalactiae Streptococcus gallolyticus ssp Lactococcus lactis gallolyticus Streptococcus infantarius ssp coli Leuconostoc mesenteroides (Str.lutetiensis) Streptococcus infantarius ssp Leuconostoc pseudomesenteroides infantarius Listeria monocytogenes Streptococcus intermedius Streptococcus mitis/ Micrococcus luteus Streptococcus oralis Micrococcus lylae Streptococcus mutans Pediococcus acidilactici Streptococcus pneumoniae Rothia mucilaginosa Streptococcus pyogenes Streptococcus salivarius ssp Staphylococcus aureus salivarius Staphylococcus capitis Streptococcus sanguinis VITEK® MS V3 Organism List GRAM-NEGATIVE ENTEROBACTERIACEAE NEW MOLD Citrobacter amalonaticus Leclercia adecarboxylata Acremonium sclerotigenum Fusarium solani complex Citrobacter braakii Morganella morganii Alternaria alternata Geotrichum candidum/klebahnii Citrobacter freundii Pantoea agglomerans Aspergillus brasiliensis Histoplasma capsulatum Citrobacter koseri Proteus mirabilis Aspergillus calidoustus Microsporum audouinii Citrobacter youngae Proteus penneri Aspergillus flavus/oryzae Microsporum canis Cronobacter sakazakii Proteus vulgaris Aspergillus fumigatus Microsporum gypseum Edwardsiella hoshinae Providencia rettgeri Aspergillus lentulus Mucor racemosus complex Edwardsiella tarda Providencia stuartii Aspergillus nidulans Penicillium chrysogenum Enterobacter aerogenes Raoultella ornithinolytica Aspergillus niger complex Pseudallescheria boydii Enterobacter asburiae Raoultella planticola Aspergillus sydowii Purpureocillium lilacinus Enterobacter cancerogenus Salmonella group Aspergillus terreus complex Rasamsonia argillacea complex Enterobacter cloacae Serratia fonticola Blastomyces dermatitidis Rhizopus arrhizus complex Enterobacter gergoviae Serratia liquefaciens Cladophialophora bantiana Rhizopus microsporus complex Escherichia coli Serratia marcescens Coccidioides immitis/posadasii Sarocladium kiliense Escherichia fergusonii Serratia odorifera Curvularia hawaiiensis Scedosporium apiospermum Escherichia hermannii Yersinia enterocolitica Curvularia spicifera Scedosporium prolificans Ewingella americana Yersinia frederiksenii Epidermophyton floccosum Sporothrix schenckii complex Hafnia alvei Yersinia intermedia Exophiala dermatitidis Trichophyton interdigitale Klebsiella oxytoca Yersinia kristensenii Exophiala xenobiotica Trichophyton rubrum Klebsiella pneumoniae Yersinia pseudotuberculosis Exserohilum rostratum Trichophyton tonsurans Fusarium oxysporum complex Trichophyton verrucosum GRAM-NEGATIVE NON-ENTEROBACTERIACEAE Fusarium proliferatum Trichophyton violaceum Achromobacter denitrificans Ochrobactrum anthropi Achromobacter xylosoxidans Pasteurella multocida NEW MYCOBACTERIA Acinetobacter baumannii complex Pseudomonas aeruginosa Mycobacterium abscessus Mycobacterium xenopi Acinetobacter haemolyticus Pseudomonas fluorescens Mycobacterium avium Mycobacterium fortuitum group Acinetobacter junii Pseudomonas putida Mycobacterium chelonae Mycobacterium alvei Acinetobacter lwoffii Pseudomonas stutzeri Mycobacterium gordonae Mycobacterium farcinogenes Aeromonas hydrophila/caviae Ralstonia pickettii Mycobacterium haemophilum Mycobacterium fortuitum Aeromonas sobria Rhizobium radiobacter Mycobacterium immunogenum Mycobacterium fortuitum spp Alcaligenes faecalis ssp faecalis Sphingobacterium multivorum Mycobacterium intracellulare fortuitum Bordetella parapertussis Sphingobacterium spiritivorum Mycobacterium kansasii Mycobacterium houstonense Bordetella pertussis Sphingomonas paucimobilis Mycobacterium lentiflavum Mycobacterium peregrinum Brevundimonas diminuta Stenotrophomonas maltophilia Mycobacterium porcinum Burkholderia multivorans Vibrio cholerae Mycobacterium malmoense Mycobacterium senegalense Chryseobacterium indologenes Vibrio parahaemolyticus Mycobacterium marinum Mycobacterium tuberculosis complex Elizabethkingia meningoseptica Vibrio vulnificus Mycobacterium mucogenicum Mycobacterium africanum Mycobacterium scrofulaceum Mycobacterium bovis GRAM-NEGATIVE FASTIDIOUS Mycobacterium simiae Mycobacterium canettii Aggregatibacter Mycobacterium smegmatis Kingella kingae actinomycetemcomitans Mycobacterium szulgai Mycobacterium tuberculosis Aggregatibacter aphrophilus Legionella pneumophila Aggregatibacter segnis Moraxella (Branhamella) catarrhalis YEAST Campylobacter coli Neisseria cinerea Candida albicans Candida pelliculosa Campylobacter jejuni Neisseria gonorrhoeae Candida dubliniensis Candida rugosa Eikenella corrodens Neisseria meningitidis Candida famata Candida tropicalis Haemophilus influenzae Neisseria mucosa/sicca Candida glabrata Candida utilis Haemophilus parahaemolyticus Oligella ureolytica Candida guilliermondii Candida zeylanoides Haemophilus parainfluenzae Oligella urethralis Candida haemulonii Cryptococcus neoformans Kingella denitrificans Candida inconspicua Kodamaea ohmeri Candida intermedia Malassezia furfur NEW NOCARDIA Candida kefyr Malassezia pachydermatis Nocardia abscessus Nocardia otitidiscaviarum Candida krusei Rhodotorula mucilaginosa Nocardia asteroides Nocardia paucivorans Candida lambica Saccharomyces cerevisiae 18-0048-00 Nocardia brasiliensis Nocardia pseudobrasiliensis Candida lipolytica Trichosporon asahii Nocardia cyriacigeorgica Nocardia transvalensis Candida lusitaniae Trichosporon inkin Nocardia farcinica Nocardia veterana Candida norvegensis Trichosporon mucoides Nocardia nova Nocardia wallacei Candida parapsilosis To place an order, visit FDA Claimed Organism List. Refer to the VITEK MS V3.0 Knowledge Base for a complete list of claimed and unclaimed organisms. www.biomerieuxDIRECT.com For more information, please contact your local bioMérieux representative or visit go.biomerieux.com/vitek-v3 bioMérieux, Inc. • 100 Rodolphe Street • Durham, NC 27712 • USA • Tel: (800) 682 2666 • Fax: (800) 968 9494 ©2018 bioMérieux, Inc. • BIOMERIEUX, the BIOMERIEUX logo and VITEK MS are used, pending and/or registered trademarks belonging to bioMérieux or one of its subsidiaries, or one of its companies. • companies. its or one of subsidiaries, its or one of bioMérieux belonging to trademarks registered pending and/or used, MS are VITEK and logo the BIOMERIEUX • BIOMERIEUX, Inc. bioMérieux, ©2018 • PRN: www.biomerieux-usa.com/patents Patents: www.biomerieux-usa.com.
Load more

Recommended publications
  • Accuprobe Mycobacterium Avium Complex Culture
    non-hybridized and hybridized probe. The labeled DNA:RNA hybrids are measured in a Hologic luminometer. A positive result is a luminometer reading equal to or greater than the cut-off. A value below this cut-off is AccuProbe® a negative result. REAGENTS Note: For information on any hazard and precautionary statements that MYCOBACTERIUM AVIUM may be associated with reagents, refer to the Safety Data Sheet Library at www.hologic.com/sds. COMPLEX CULTURE Reagents for the ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX IDENTIFICATION TEST CULTURE IDENTIFICATION TEST are provided in three separate reagent kits: INTENDED USE The ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX CULTURE ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX PROBE KIT IDENTIFICATION TEST is a rapid DNA probe test which utilizes the Probe Reagent. (4 x 5 tubes) technique of nucleic acid hybridization for the identification of Mycobacterium avium complex Mycobacterium avium complex (M. avium complex) isolated from culture. Lysing Reagent. (1 x 20 tubes) Glass beads and buffer SUMMARY AND EXPLANATION OF THE TEST Infections caused by members of the M. avium complex are the most ACCUPROBE CULTURE IDENTIFICATION REAGENT KIT common mycobacterial infections associated with AIDS and other Reagent 1 (Lysis Reagent). 1 x 10 mL immunocompromised patients (7,15). The incidence of M. avium buffered solution containing 0.04% sodium azide complex as a clinically significant pathogen in cases of chronic pulmonary disease is also increasing (8,17). Recently, several Reagent 2 (Hybridization Buffer). 1 x 10 mL laboratories have reported that the frequency of isolating M. avium buffered solution complex is equivalent to or greater than the frequency of isolating M.
    [Show full text]
  • Artus Mycobac. Diff. LC PCR Kit Handbook 10/2015 2
    October 2015 artus® Mycobac. diff. LC PCR Kit Handbook 24 96 Version 1 Quantitative in vitro diagnostics For use with the LightCycler® 1.1/1.2/1.5 and LightCycler 2.0 instruments 4556063 (24 reactions) 4556065 (96 reactions) QIAGEN GmbH QIAGEN Strasse 1 40724 Hilden GERMANY R4 1046963EN Sample to Insight__ Contents Summary and Explanation ...................................................................................................4 Principle of the Procedure ....................................................................................................4 Materials Provided .............................................................................................................6 Kit contents ..............................................................................................................6 Materials Required but Not Provided ....................................................................................7 Warnings and Precautions ..................................................................................................8 Warnings ................................................................................................................8 Reagent Storage and Handling ............................................................................................8 Procedure ..........................................................................................................................9 Important points before starting ..................................................................................9
    [Show full text]
  • ID 2 | Issue No: 4.1 | Issue Date: 29.10.14 | Page: 1 of 24 © Crown Copyright 2014 Identification of Corynebacterium Species
    UK Standards for Microbiology Investigations Identification of Corynebacterium species Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 1 of 24 © Crown copyright 2014 Identification of Corynebacterium species Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 2 of 24 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Corynebacterium species Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]
  • An Enhanced Characterization of the Human Skin Microbiome
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.21.914820; this version posted January 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 An enhanced characterization of the human skin microbiome: a new biodiversity of 2 microbial interactions 3 4 Akintunde Emiola1, Wei Zhou1, Julia Oh1* 5 6 1The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA 7 *Corresponding author. [email protected] 8 9 10 ABSTRACT 11 12 The healthy human skin microbiome is shaped by skin site physiology, individual-specific factors, 13 and is largely stable over time despite significant environmental perturbation. Studies identifying 14 these characteristics used shotgun metagenomic sequencing for high resolution reconstruction 15 of the bacteria, fungi, and viruses in the community. However, these conclusions were drawn from 16 a relatively small proportion of the total sequence reads analyzable by mapping to known 17 reference genomes. ‘Reference-free’ approaches, based on de novo assembly of reads into 18 genome fragments, are also limited in their ability to capture low abundance species, small 19 genomes, and to discriminate between more similar genomes. To account for the large fraction 20 of non-human unmapped reads on the skin—referred to as microbial ‘dark matter’—we used a 21 hybrid de novo and reference-based approach to annotate a metagenomic dataset of 698 healthy 22 human skin samples. This approach reduced the overall proportion of uncharacterized reads from 23 42% to 17%. With our refined characterization, we revisited assumptions about the skin 24 microbiome, and demonstrated higher biodiversity and lower stability, particularly in dry and moist 25 skin sites.
    [Show full text]
  • BD™ Gardnerella Selective Agar with 5% Human Blood
    INSTRUCTIONS FOR USE – READY-TO-USE PLATED MEDIA PA-254094.06 Rev.: July 2014 BD Gardnerella Selective Agar with 5% Human Blood INTENDED USE BD Gardnerella Selective Agar with 5% Human Blood is a partially selective and differential medium for the isolation of Gardnerella vaginalis from clinical specimens. PRINCIPLES AND EXPLANATION OF THE PROCEDURE Microbiological method. Gardnerella vaginalis is considered to be one of the organisms causing vaginitis.1-4 Although the organism may be present in a high percentage of normal women in the vaginal flora, its importance as a cause of non-specific vaginitis (also called bacterial vaginosis) has never been questioned. In symptomatic women, G. vaginalis frequently is associated with anaerobes such as Prevotella bivia, P. disiens, Mobiluncus, Peptostreptococcus, and/or others which are a regular part of the urethral or intestinal, but not vaginal flora. In non-specific vaginitis, normal Lactobacillus flora is reduced or absent. Gardnerella vaginalis is considered to be the indicator organism for non-specific vaginitis which, in fact, is a polymicrobial infection.3,4 Although non- culture methods such as a direct Gram stain have been recommended in recent years for genital specimens, culture is still preferred by many laboratories.1,5 G. vaginalis may also be responsible for a variety of other diseases such as preterm birth, chorioamnionitis, urinary tract infections, newborn infections, and septicemia.6 The detection of the organism on routinely used media is difficult since Gardnerella and other
    [Show full text]
  • Corynebacterium Species Rarely Cause Orthopedic Infections
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2018 Corynebacterium species rarely cause orthopedic infections Kalt, Fabian ; Schulthess, Bettina ; Sidler, Fabian ; Herren, Sebastian ; Fucentese, Sandro F ; Zingg, Patrick O ; Berli, Martin ; Zinkernagel, Annelies S ; Zbinden, Reinhard ; Achermann, Yvonne Abstract: Corynebacterium spp. are rarely considered as pathogens but data in orthopedic infections are sparse. Therefore, we asked how often Corynebacterium spp. caused an infection in a defined cohort of orthopedic patients with a positive culture. In addition, we aimed to determine the species variety and susceptibility of isolated strains in regards to potential treatment strategies. Between 2006 and 2015, we retrospectively assessed all Corynebacterium sp. bone and joint cultures from an orthopedic ward. The isolates were considered as relevant indicating an infection if the same Corynebacterium sp. was present in at least two samples. We found 97 orthopedic cases with isolation of Corynebacterium spp. (128 positive samples), mainly Corynebacterium tuberculostearicum (n=26), Corynebacterium amycolatum (n=17), Corynebacterium striatum (n=13), and Corynebacterium afermentans (n=11). Compared to a cohort of positive blood cultures, we found significantly more C. striatum and C. tuberculostearicum but no C. jeikeium cases. Only 16 cases out 66 cases (24.2%) with an available diagnostic set of at least 2 samples had an infection. Antibiotic susceptibility testing (AST) of different antibiotics showed various susceptibility results except for vancomycin and linezolid with a 100% susceptibility rate. Rates of susceptibility of corynebacteria isolated from orthopedic samples and of isolates from blood cultures were comparable. In conclusion, our study results confirmed that Corynebacterium sp.
    [Show full text]
  • Actinomycesspp & Nocardiaspp
    PLUMB’S THERAPEUTICS BRIEF h PATHOGEN PROFILE h PEER REVIEWED Actinomyces spp & Nocardia spp J. Scott Weese, DVM, DVSc, DACVIM University of Guelph Actinomyces spp and Nocardia spp are members of class Acti- Nocardia spp nobacteria, which can cause opportunistic infections in dogs, The Nocardia genus contains more than 30 saprophytic species cats, and other species. Both can cause pyogranulomatous or that are widely, if not ubiquitously, disseminated in the environ- suppurative disease that is often slowly progressing and chal- ment. Disease occurs following inoculation of the bacterium into lenging to diagnose; however, some differences in organism tissue or via inhalation. and characteristics exist (Table 1, next page). The incidence of h Nocardia spp are regionally variable, with higher rates of disease caused by either is undefined and likely low. infection in dry, dusty, and windy regions (eg, southwestern United States, parts of Australia). Actinomyces spp h Nocardiosis is classically divided into 3 clinical forms: Many different species are present, and taxonomy continues to pulmonary, disseminated (systemic), and cutaneous/ change; some species previously known as Actinomyces have subcutaneous.11-15 been reclassified in other genera, such as Arcanobacterium spp • Clinical presentations are as would be expected with pul- and Trueperella spp. Regardless, disease aspects remain monary, systemic, or cutaneous infections. Pulmonary or unchanged. Commonly found as part of the oral, GI, and genital cutaneous disease can progress to disseminated disease. microbiotas,1-3 Actinomyces spp and related genera are of lim- ited virulence unless inoculated into tissue (eg, via bites, foreign Diagnosis bodies, or trauma). Early diagnosis may be missed.
    [Show full text]
  • Human Microbiota Network: Unveiling Potential Crosstalk Between the Different Microbiota Ecosystems and Their Role in Health and Disease
    nutrients Review Human Microbiota Network: Unveiling Potential Crosstalk between the Different Microbiota Ecosystems and Their Role in Health and Disease Jose E. Martínez †, Augusto Vargas † , Tania Pérez-Sánchez , Ignacio J. Encío , Miriam Cabello-Olmo * and Miguel Barajas * Biochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain; [email protected] (J.E.M.); [email protected] (A.V.); [email protected] (T.P.-S.); [email protected] (I.J.E.) * Correspondence: [email protected] (M.C.-O.); [email protected] (M.B.) † These authors contributed equally to this work. Abstract: The human body is host to a large number of microorganisms which conform the human microbiota, that is known to play an important role in health and disease. Although most of the microorganisms that coexist with us are located in the gut, microbial cells present in other locations (like skin, respiratory tract, genitourinary tract, and the vaginal zone in women) also play a significant role regulating host health. The fact that there are different kinds of microbiota in different body areas does not mean they are independent. It is plausible that connection exist, and different studies have shown that the microbiota present in different zones of the human body has the capability of communicating through secondary metabolites. In this sense, dysbiosis in one body compartment Citation: Martínez, J.E.; Vargas, A.; may negatively affect distal areas and contribute to the development of diseases. Accordingly, it Pérez-Sánchez, T.; Encío, I.J.; could be hypothesized that the whole set of microbial cells that inhabit the human body form a Cabello-Olmo, M.; Barajas, M.
    [Show full text]
  • JET Microbiological Efficacy Summary
    Microbiological Efficacy Summary Testing performed in accordance to European Standard EN 14885:2018 ORGANISM TEST NORM TEST TYPE CONDITIONS Bacillus subtilis EN 13704 Suspension Clean 1 and Dirty 1 Bacillus cereus SPORICIDAL Mycobacterium terrae EN 14563 Carrier Clean 1 and Dirty 2 Mycobacterium avium Mycobacterium terrae EN 14348 Suspension Clean 1 Mycobacterium avium MYCOBACTERICIDAL Poliovirus Type 1 Adenovirus Type 5 EN 14476 Suspension Clean 1 Murine Norovirus VIRUCIDAL Candida albicans EN 16615 Surface with mechanical action Candida albicans EN 13697 Surface Aspergillus brasiliensis EN 14562 Carrier Clean 1 Candida albicans YEASTICIDAL FUNGICIDAL / FUNGICIDAL Aspergillus brasiliensis EN 13624 Suspension Candida albicans Staphylococcus aureus Enterococcus hirae EN 16615 Surface with mechanical action Pseudomonas aeruginosa Enterococcus hirae Staphylococcus aureus EN 13697 Surface Clean 1 Pseudomonas aeruginosa Escherichia coli Staphylococcus aureus BACTERICIDAL Enterococcus hirae EN 14561 Carrier Pseudomonas aeruginosa Staphylococcus aureus Enterococcus hirae EN 13727 Suspension Clean 1 and Dirty 1 Pseudomonas aeruginosa TRISTEL’S CLEANING AND DISINFECTION BRAND FOR HOSPITAL SURFACES Page 1 of 3 Additional Testing TEST METHOD RNA DNA / Polyacrylamide gel electrophoresis (PAGE) ORGANISM TEST METHOD TEST TYPE CONDITIONS Acanthamoeba castellanii cysts Following the method of EN 13704 Suspension Clean 1 PROTOZOA Bacillus subtilis EN 17126 Suspension Clean 1 Bacillus cereus Clostridium difficile EN 13704 Suspension Clean 1 and Dirty 1
    [Show full text]
  • NOTES in Vitro Activities of Norfloxacin and Ciprofloxacin Against
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1984, p. 94-96 Vol. 26, No. 1 0066-4804/84/070094-03$02.00/0 Copyright C 1984, American Society for Microbiology NOTES In Vitro Activities of Norfloxacin and Ciprofloxacin Against Mycobacterium tuberculosis, M. avium Complex, M. chelonei, M. fortuitum, and M. kansasii J. DOUGLAS GAY, DONALD R. DEYOUNG, AND GLENN D. ROBERTS* Section of Clinical Microbiology, Department of Laboratory Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905 Received 28 November 1983/Accepted 4 April 1984 The activities of ciprofloxacin and norfloxacin against 100 mycobacteria isolates were studied in vitro by the 1% standard proportion method. Ciprofloxacin was more active against M. tuberculosis and M. fortuitum with MICs of 1.0 and 0.25 ,ug/ml, respectively, against 90% of isolates; norfloxacin had MICs of 8.0 and 2.0 ,ug/ml, respectively, against 90% of isolates. Nalidixic acid and other heterocyclic carbonic acid deriva- studied. The organisms were taken from the Mayo Clinic tives have been used primarily in the treatment of urinary stock culture collection, which included recent clinical iso- tract infections for many years. The compounds of this lates. Stock cultures were maintained on Middlebrook 7H10 general group include nalidixic acid, oxolinic acid, pipemidic agar slants (Difco Laboratories, Detroit, Mich.) and were acid, cinoxacin, and rosoxacin. Two new substances in this subcultured monthly. The identification of isolates was series which have been recently synthesized are norfloxacin based on standard biochemical tests (17) and gas-liquid (6) (1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[ 1-piperazinyl ]-3- chromatography (16).
    [Show full text]
  • MICROBIOLOGY LEGEND CYCLE 36 ORGANISM 5 Corynebacterium
    P.O. Box 131375, Bryanston, 2074 Ground Floor, Block 5 Bryanston Gate, 170 Curzon Road Bryanston, Johannesburg, South Africa 804 Flatrock, Buiten Street, Cape Town, 8001 www.thistle.co.za Tel: +27 (011) 463 3260 Fax: +27 (011) 463 3036 Fax to Email: + 27 (0) 86-557-2232 e-mail : [email protected] Please read this section first The HPCSA and the Med Tech Society have confirmed that this clinical case study, plus your routine review of your EQA reports from Thistle QA, should be documented as a “Journal Club” activity. This means that you must record those attending for CEU purposes. Thistle will not issue a certificate to cover these activities, nor send out “correct” answers to the CEU questions at the end of this case study. The Thistle QA CEU No is: MT-2014/004. Each attendee should claim THREE CEU points for completing this Quality Control Journal Club exercise, and retain a copy of the relevant Thistle QA Participation Certificate as proof of registration on a Thistle QA EQA. MICROBIOLOGY LEGEND CYCLE 36 ORGANISM 5 Corynebacterium Corynebacteria (from the Greek words koryne, meaning club, and bacterion, meaning little rod) are gram-positive, catalase-positive, aerobic or facultatively anaerobic, generally nonmotile rods. The genus contains the species Corynebacterium diphtheriae and the nondiphtherial Corynebacteria, collectively referred to as diphtheroids. Nondiphtherial Corynebacteria, originally thought to be mainly contaminants, have increasingly over the past 2 decades been recognized as pathogenic, especially in the elderly and immunocompromised hosts. They are ubiquitous in nature and commonly colonize human skin and mucous membranes.
    [Show full text]
  • A Genomic Journey Through a Genus of Large DNA Viruses
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Virology Papers Virology, Nebraska Center for 2013 Towards defining the chloroviruses: a genomic journey through a genus of large DNA viruses Adrien Jeanniard Aix-Marseille Université David D. Dunigan University of Nebraska-Lincoln, [email protected] James Gurnon University of Nebraska-Lincoln, [email protected] Irina V. Agarkova University of Nebraska-Lincoln, [email protected] Ming Kang University of Nebraska-Lincoln, [email protected] See next page for additional authors Follow this and additional works at: https://digitalcommons.unl.edu/virologypub Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell and Developmental Biology Commons, Genetics and Genomics Commons, Infectious Disease Commons, Medical Immunology Commons, Medical Pathology Commons, and the Virology Commons Jeanniard, Adrien; Dunigan, David D.; Gurnon, James; Agarkova, Irina V.; Kang, Ming; Vitek, Jason; Duncan, Garry; McClung, O William; Larsen, Megan; Claverie, Jean-Michel; Van Etten, James L.; and Blanc, Guillaume, "Towards defining the chloroviruses: a genomic journey through a genus of large DNA viruses" (2013). Virology Papers. 245. https://digitalcommons.unl.edu/virologypub/245 This Article is brought to you for free and open access by the Virology, Nebraska Center for at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Virology Papers by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Adrien Jeanniard, David D. Dunigan, James Gurnon, Irina V. Agarkova, Ming Kang, Jason Vitek, Garry Duncan, O William McClung, Megan Larsen, Jean-Michel Claverie, James L. Van Etten, and Guillaume Blanc This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/ virologypub/245 Jeanniard, Dunigan, Gurnon, Agarkova, Kang, Vitek, Duncan, McClung, Larsen, Claverie, Van Etten & Blanc in BMC Genomics (2013) 14.
    [Show full text]